Studies of pancreatic alpha cell function in normal and diabetic subjects
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
The development of a glucagon radioimmunoassay with a relatively high degree of specificity for pancreatic glucagon made possible studies of alpha cell function in healthy nondiabetic subjects and in patients with diabetes mellitus. In the former group mean fasting plasma glucagon averaged 108 mumug/ml (SEM +/-10). In 12 juvenile-type diabetics fasting glucagon averaged 110 (+/-9) and in 33 adult-type diabetics the average was 114 (+/-8). The diabetic averages did not differ significantly from the nondiabetic subjects; however, when hyperglycemia was induced by glucose infusion in the nondiabetic subjects so as to simulate the fasting hyperglycemia of the diabetics, mean glucagon fell to 57 mumug (+/-8), which was significantly below the diabetic mean. In 28 healthy subjects the infusion of arginine elicited a rise in glucagon of at least 100 mumug/ml with a peak level averaging 331 mumug/ml (+/-22) at 40 min. This response to arginine was diminished but not abolished during hyperglycemia induced by simultaneous glucose infusion. In everyone of 45 diabetic subjects tested the infusion of arginine elicited a rise in glucagon of at least 140 mumug/ml to levels significantly greater than in nondiabetics. The peak glucagon level in juvenile-type diabetics averaged 458 mumug/ml (SEM +/-36) and in adult-type diabetics averaged 452 mumug/ml (SEM +/-38). The glucagon response to arginine was unrelated to duration of diabetes, to body weight, type of diabetic treatment, or to other known factors. Marked hyperresponsiveness of glucagon to arginine infusion was observed in two patients with advanced Kimmelsteil-Wilson disease. Glucagon levels were markedly elevated in certain patients with severe diabetic ketoacidosis before treatment with insulin. The findings suggest that alpha cell function is inappropriately increased in diabetes mellitus and could play a significant role in the diabetic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Coated Charcoal Immunoassay of Insulin
HERBERT, V., LAU, K.-S., GOTTLIEB, C. W., & BLEICHER, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,968
(1952) · Diabetes · doi:10.2337/diab.1.2.159 · Cited by 1,447
A RAPID PHOTOELECTRIC METHOD FOR THE DETERMINATION OF GLUCOSE IN BLOOD AND URINE
Hoffman, W. S. (1937) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)74360-3 · Cited by 1,286
Siperstein, M. D., Unger, R. H., & Madison, L. L. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105886 · Cited by 592
Self-citationExcessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay
Karam, J. H., Grodsky, G. M., Forsham, P. H., & McWilliams, N. B. (1963) · Diabetes · doi:10.2337/diab.12.3.197 · Cited by 591
Pancreatic Glucagon Secretion in Normal and Diabetic Subjects
Aguilar-Parada, E., Eisentraut, A. M., & Unger, R. H. (1969) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196906000-00008 · Cited by 535
Self-citationIMMUNOASSAY OF ENDOGENOUS PLASMA INSULIN IN MAN
YALOW, R. S., & BERSON, S. A. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00274.x · Cited by 460
THE EFFECTS OF TOTAL STARVATION UPON THE LEVELS OF CIRCULATING GLUCAGON AND INSULIN IN MAN*
Unger, R. H., Eisentraut, A. M., & Madison, L. L. (1963) · Journal of Clinical Investigation · doi:10.1172/jci104788 · Cited by 345
Self-citationUnger, R. H., Ketterer, H., Dupré, J., & Eisentraut, A. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105565 · Cited by 337
Self-citation
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Metabolism disrupting chemicals and metabolic disorders
Heindel, J. J., Blumberg, B., Cave, M., Machtinger, R., Mantovani, A., Mendez, M. A., Nadal, A., Palanza, P., Panzica, G., Sargis, R., et al. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.10.001 · Cited by 1,101
“glycogenolysis and gluconeogenesis to raise circulating blood sugar [132, 133].”
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
Metadata
- Authors
- Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M.
- Affiliations
- American Society for Clinical Investigation (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1970-04-01
- Volume
- 49
- Issue
- 4
- Pages
- 837-848
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC322540
- OpenAlex
- W2146415791
- Cited by
- 837
- References
- 28
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 18 · 2023: 14 · 2022: 8 · 2021: 11 · 2020: 14 · 2019: 18 · 2018: 24 · 2017: 12 · 2016: 15 · 2015: 16 · 2014: 15 · 2013: 4 · 2012: 12
- FWCI
- 83.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Pfizer
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- alpha cells, glucagon secretion, diabetes mellitus, arginine stimulation, hyperglycemia, diabetic ketoacidosis, type 1 diabetes, type 2 diabetes
- MeSH terms
- Adolescent, Adult, Arginine, Body Weight, Child, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Fasting, Glucagon, Glucose, Humans, Hyperglycemia, Insulin, Middle Aged, Pancreas, Radioimmunoassay, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Studies of pancreatic alpha cell function in normal and diabetic subjects. https://app.cochat.ai/papers/10.1172/jci106297
- The paper
- Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M. (1970). Studies of pancreatic alpha cell function in normal and diabetic subjects. Journal of Clinical Investigation. https://doi.org/10.1172/jci106297
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.